Records containing: Hormone-Resistant Prostate Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-03PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)
-
CLINICAL_TRIALS study record update · 2025-01-24St. Judes-Stanford Comprehensive Support Initiative
-
CLINICAL_TRIALS study record update · 2025-01-20Addition of Pembrolizumab Upon Progression on Enzalutamide in Men With mCRPC
-
CLINICAL_TRIALS study record update · 2023-05-01A Single-Arm, Open-Label, Two-Stage Phase II Study of the MEK 1/2 Inhibitor Trametinib in Men With Progressive Metastatic Castrate Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2022-12-01Pilot Trial of pTVG-HP DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-08-08A Randomized Phase 2 Trial of Ascorbic Acid in Combination With Docetaxel in Men With Metastatic Prostate Cancer
-
CLINICAL_TRIALS study record update · 2022-03-10Correlation of Serum Catecholamine With Emotional Stress in Men With Prostate Cancer: A Pilot Study
-
CLINICAL_TRIALS study record update · 2021-08-05A Phase 2 Study of Docetaxel and Carboplatin for Treatment of Patients With Metastatic, Castration Resistant Prostate Cancer and Germline or Somatic DNA Repair Deficiency
-
CLINICAL_TRIALS study record update · 2021-08-05Pilot: Impact of High-Dose, Single Fraction Radiation on Immunogenicity of Sipuleucel-T in Metastatic Castration Recurrent Prostate Cancer Patients
-
CLINICAL_TRIALS study record update · 2021-05-14Open Label Pharmacodynamic Study of Abiraterone Acetate in the Treatment of Metastatic, Castration Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2021-04-05Studies of Cell-Free DNA and RNA in Blood From Patients Being Treated for Prostate Cancer
-
CLINICAL_TRIALS study record update · 2021-01-25A Selective Frontline Cabazitaxel Therapeutic Pathway for Castration-Resistant Prostate Cancer With Integrated Biomarkers
-
CLINICAL_TRIALS study record update · 2019-06-17Phase I/II Trial of Anti-IGF-IR Monoclonal Antibody IMC-A12 Plus mTOR Inhibitor Temsirolimus (CCI-779) in Metastatic Castration-Resistant Prostate Cancer (CRPC)
-
CLINICAL_TRIALS study record update · 2018-09-12A Randomized, Double-Blind, Placebo-Controlled Phase II Study of ARQ 197 (Tivantinib) in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2018-07-12A Pilot Study of Dexamethasone Therapy Prior to Rechallenge With Enzalutamide in Men With Metastatic Castration-Resistant Prostate Cancer Dex EXTends Enza Response (The DEXTER Trial)
-
CLINICAL_TRIALS study record update · 2018-06-26Phase II Single Agent Study of Selinexor (KPT-330) in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Prior Therapy With Abiraterone and/or Enzalutamide
-
CLINICAL_TRIALS study record update · 2018-01-17Durvalumab (MEDI4736) in Hypermutated Metastatic Castration-Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2017-12-11A Phase II Study of MAOA Inhibitor Plus Docetaxel in Patients Receiving and Progressing on Docetaxel Therapy
-
CLINICAL_TRIALS study record update · 2017-05-30Combined "One Stop Shop" NaF/FDG PET/MRI Evaluation of Response to Xofigo® in mCRPC Patients: A Pilot Study
-
CLINICAL_TRIALS study record update · 2017-05-24A Phase 2 Study of GW786034 (Pazopanib) With or Without Bicalutamide in Hormone Refractory Prostate Cancer
-
CLINICAL_TRIALS study record update · 2017-04-24A Phase I Study of Single Agent Talazoparib (BMN 673) in Advanced Cancer Patients With Hepatic and Renal Dysfunction
-
CLINICAL_TRIALS study record update · 2017-04-17Assessment of Novel Biomarkers in Patients With Metastatic Castration Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2016-10-04A Phase I Clinical Trial of mTOR Inhibition With Rapamycin for Enhancing Intranodal Dendritic Cell Vaccine Induced Anti-tumor Immunity in Patients With NY-ESO-1 Expressing Solid Tumors
-
CLINICAL_TRIALS study record update · 2016-05-20A Phase II Randomized Open Label Study of Sipuleucel-T vs. Sipuleucel-T and Tasquinimod in Patients With Metastatic Castrate-Resistant Prostate Cancer (CRPC)
-
CLINICAL_TRIALS study record update · 2015-07-16A Phase 2, Multicenter Evaluation of 18F-Fluoride PET as a Pharmacodynamic Biomarker for Dasatinib, a Src Kinase Inhibitor, in Men With Castration-Resistant Prostate Cancer and Bone Metastases (BMS #180-279)